Microbix Biosystems Inc. (TSX:MBX)
Canada · Delayed Price · Currency is CAD 0.3000
+0.0100 (3.45%)
Aug 10, 2026, 3:20 PM EST
Microbix Biosystems Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 14.81 | 18.59 | 25.39 | 16.51 | 19.08 | 18.59 | |
Revenue Growth | -34.81% | -26.81% | 53.77% | -13.43% | 2.60% | 76.66% |
Cost of Revenue | 8.52 | 8.73 | 10 | 9.03 | 7.95 | 7.55 |
Gross Profit | 6.29 | 9.85 | 15.39 | 7.48 | 11.12 | 11.04 |
Selling, General & Admin | 8.87 | 9.1 | 9.37 | 8.17 | 6.72 | 5.17 |
Research & Development | 2.38 | 2.33 | 2.13 | 2.05 | 1.8 | 1.03 |
Other Operating Expenses | 0.13 | 0.13 | -0.01 | 3.08 | - | - |
Total Operating Expenses | 11.37 | 11.56 | 11.49 | 13.3 | 8.51 | 6.21 |
Operating Income | -5.08 | -1.71 | 3.91 | -5.82 | 2.61 | 4.84 |
Total Non-Operating Income (Expense) | 0.7 | 0.6 | 0.23 | 0.38 | 0.74 | 1.09 |
Pretax Income | -4.38 | -1.11 | 4.14 | -5.43 | 3.35 | 5.92 |
Provision for Income Taxes | - | -0.06 | 0.15 | - | 0.08 | - |
Net Income | -5.72 | -2.25 | 3.52 | -0.04 | 1.79 | 3.23 |
Net Income to Common | -5.72 | -2.25 | 3.52 | -0.04 | 1.79 | 3.23 |
Net Income Growth | - | - | - | - | -44.68% | - |
Shares Outstanding (Basic) | 139 | 139 | 138 | 138 | 135 | 115 |
Shares Outstanding (Diluted) | 139 | 139 | 138 | 138 | 142 | 142 |
Shares Change | 0.09% | 0.48% | 0.42% | -2.67% | 0.00% | 26.40% |
EPS (Basic) | -0.04 | -0.02 | 0.03 | - | 0.01 | 0.03 |
EPS (Diluted) | -0.04 | -0.02 | 0.03 | - | 0.01 | 0.03 |
EPS Growth | - | - | - | - | -50.00% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -5.49 | -0.88 | 2.71 | -2.11 | 1.44 | 0.86 |
Free Cash Flow Growth | - | - | - | - | 66.64% | - |
Free Cash Flow Per Share | -0.04 | -0.01 | 0.02 | -0.02 | 0.01 | 0.01 |
Gross Margin | 42.49% | 53.02% | 60.61% | 45.30% | 58.32% | 59.40% |
Operating Margin | -34.28% | -9.18% | 15.38% | -35.21% | 13.68% | 26.01% |
Profit Margin | -38.62% | -12.08% | 13.86% | -0.24% | 9.38% | 17.39% |
FCF Margin | -37.07% | -4.72% | 10.68% | -12.78% | 7.55% | 4.65% |
EBITDA | -3.24 | 0.07 | 5.52 | -4.66 | 3.65 | 5.66 |
EBITDA Margin | -21.88% | 0.40% | 21.73% | -28.20% | 19.12% | 30.43% |
EBIT | -5.08 | -1.71 | 3.91 | -5.82 | 2.61 | 4.84 |
EBIT Margin | -34.28% | -9.18% | 15.38% | -35.21% | 13.68% | 26.01% |
Effective Tax Rate | - | 5.02% | 3.64% | 0.00% | 2.30% | 0.00% |